Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D [Phase 3]

View source ↗

Summary

A Phase 3 study to evaluate the efficacy and safety of Live SK08 Powder in patients with Irritable bowel syndrome with diarrhea is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Live SK08 Powder

Snippet

Sponsor: Guangzhou Zhiyi Biotechnology Co., Ltd. | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 3 | Status: RECRUITING